Trial Profile
Comparison of the renoprotective and antihypertensive effects of Olmesartan vs Losartan + low dose diuretics in normoalbuminuric diabetic patients
Status:
Recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 11 Jun 2007
Price :
$35
*
At a glance
- Drugs Olmesartan medoxomil (Primary) ; Hydrochlorothiazide; Losartan; Thiazide diuretics
- Indications Hypertension
- Focus Pharmacodynamics
- 11 Jun 2007 New trial record.